172 related articles for article (PubMed ID: 23292863)
1. CD147, MMP9 expression and clinical significance of basal-like breast cancer.
Liu Y; Xin T; Jiang QY; Huang DY; Shen WX; Li L; Lv YJ; Jin YH; Song XW; Teng C
Med Oncol; 2013 Mar; 30(1):366. PubMed ID: 23292863
[TBL] [Abstract][Full Text] [Related]
2. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q
Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
4. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
5. CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.
Liu M; Tsang JYS; Lee M; Ni YB; Chan SK; Cheung SY; Hu J; Hu H; Tse GMK
J Clin Pathol; 2018 Nov; 71(11):1007-1014. PubMed ID: 30099407
[TBL] [Abstract][Full Text] [Related]
6. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
Xue YJ; Lu Q; Sun ZX
Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
[TBL] [Abstract][Full Text] [Related]
7. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W
BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Yu W; Liu J; Xiong X; Ai Y; Wang H
Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
[TBL] [Abstract][Full Text] [Related]
13. CD147 expression indicates unfavourable prognosis in prostate cancer.
Han ZD; Bi XC; Qin WJ; He HC; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Chen ZN; Zhong WD
Pathol Oncol Res; 2009 Sep; 15(3):369-74. PubMed ID: 19048397
[TBL] [Abstract][Full Text] [Related]
14. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of basal cytokeratin expression in breast cancer.
Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
[TBL] [Abstract][Full Text] [Related]
16. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
[TBL] [Abstract][Full Text] [Related]
17. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
18. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z
Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553
[TBL] [Abstract][Full Text] [Related]
19. Expression of IFN-induced 2'-5'-oligoadenylate synthetases correlates with immune infiltration, revealing potential targets and new biomarkers for basal-like breast cancer prognosis.
Zhao J; Zhang X; Cheng M; Guan J; Gai J; Fu L; Zhang R; Du T; Li Q
Int Immunopharmacol; 2020 Nov; 88():106916. PubMed ID: 32882665
[TBL] [Abstract][Full Text] [Related]
20. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
